tiprankstipranks
Advertisement
Advertisement
Aurinia Pharmaceuticals up 4% in pre-market after insider transactions
PremiumThe FlyAurinia Pharmaceuticals up 4% in pre-market after insider transactions
1M ago
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
Premium
Company Announcements
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
2M ago
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
Premium
The Fly
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
2M ago
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
PremiumCompany AnnouncementsAurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
4M ago
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
4M ago
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
Premium
The Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
4M ago
Aurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
PremiumCompany AnnouncementsAurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
4M ago
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
Premium
Company Announcements
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
5M ago
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
Premium
Company Announcements
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100